U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06934577) titled 'Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2' on April 10.
Brief Summary: To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Eye Diseases
Visual Impairment
Glaucoma
Intervention:
OTHER: Standard optometric examination
Participants will see the optometrist at the Federally Qualified Health C...